WO1997009068A3 - Interactive molecular conjugates - Google Patents
Interactive molecular conjugates Download PDFInfo
- Publication number
- WO1997009068A3 WO1997009068A3 PCT/US1996/013874 US9613874W WO9709068A3 WO 1997009068 A3 WO1997009068 A3 WO 1997009068A3 US 9613874 W US9613874 W US 9613874W WO 9709068 A3 WO9709068 A3 WO 9709068A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- binding
- binding site
- site
- stimuli
- ligands
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6891—Pre-targeting systems involving an antibody for targeting specific cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6891—Pre-targeting systems involving an antibody for targeting specific cells
- A61K47/6897—Pre-targeting systems with two or three steps using antibody conjugates; Ligand-antiligand therapies
- A61K47/6898—Pre-targeting systems with two or three steps using antibody conjugates; Ligand-antiligand therapies using avidin- or biotin-conjugated antibodies
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT96931427T ATE216594T1 (en) | 1995-09-01 | 1996-08-30 | INTERACTIVE MOLECULAR CONJUGATES |
JP9511275A JP2000500733A (en) | 1995-09-01 | 1996-08-30 | Interacting molecular conjugate |
AU70110/96A AU716154B2 (en) | 1995-09-01 | 1996-08-30 | Interactive molecular conjugates |
EP96931427A EP0851768B1 (en) | 1995-09-01 | 1996-08-30 | Interactive molecular conjugates |
DE69620898T DE69620898T2 (en) | 1995-09-01 | 1996-08-30 | INTERACTIVE MOLECULAR CONJUGATES |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US314895P | 1995-09-01 | 1995-09-01 | |
US60/003,148 | 1995-09-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1997009068A2 WO1997009068A2 (en) | 1997-03-13 |
WO1997009068A3 true WO1997009068A3 (en) | 1997-08-28 |
Family
ID=21704411
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1996/013874 WO1997009068A2 (en) | 1995-09-01 | 1996-08-30 | Interactive molecular conjugates |
Country Status (8)
Country | Link |
---|---|
US (1) | US5998588A (en) |
EP (1) | EP0851768B1 (en) |
JP (1) | JP2000500733A (en) |
AT (1) | ATE216594T1 (en) |
AU (1) | AU716154B2 (en) |
CA (1) | CA2230557A1 (en) |
DE (1) | DE69620898T2 (en) |
WO (1) | WO1997009068A2 (en) |
Families Citing this family (127)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7812149B2 (en) | 1996-06-06 | 2010-10-12 | Isis Pharmaceuticals, Inc. | 2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations |
US5898031A (en) | 1996-06-06 | 1999-04-27 | Isis Pharmaceuticals, Inc. | Oligoribonucleotides for cleaving RNA |
US9096636B2 (en) | 1996-06-06 | 2015-08-04 | Isis Pharmaceuticals, Inc. | Chimeric oligomeric compounds and their use in gene modulation |
CA2291622C (en) | 1997-06-06 | 2007-09-04 | Anna Gutowska | Reversible geling co-polymer and method of making |
AU2002301047B2 (en) * | 1997-06-20 | 2005-11-10 | Ciphergen Biosystems, Inc. | Retentate Chromatography And Protein Chip Arrays With Applications In Biology And Medicine |
NZ516848A (en) * | 1997-06-20 | 2004-03-26 | Ciphergen Biosystems Inc | Retentate chromatography apparatus with applications in biology and medicine |
DE69839323T2 (en) * | 1997-12-09 | 2009-04-09 | National Institute Of Advanced Industrial Science And Technology | Stimulus-responsive polymer via keto-enol tautomerism |
GB9726888D0 (en) * | 1997-12-20 | 1998-02-18 | Eev Ltd | Detection |
ATE443528T1 (en) * | 1998-01-05 | 2009-10-15 | Univ Washington | INCREASED TRANSPORT USING MEMBRANE-DESTRUCTIVE SUBSTANCES |
US6296831B1 (en) * | 1998-04-10 | 2001-10-02 | Battelle Memorial Institute | Stimulus sensitive gel with radioisotope and methods of making |
EP1006362A1 (en) * | 1998-12-02 | 2000-06-07 | Michael Dr. Cahill | Method and apparatus for the separation of components from a biological material |
WO2000056774A1 (en) * | 1999-03-19 | 2000-09-28 | Duke University | Methods of using bioelastomers |
GB9923146D0 (en) * | 1999-09-30 | 1999-12-01 | Imperial College | Detector array |
US6258275B1 (en) * | 1999-10-01 | 2001-07-10 | Ecole Polytechnique Federale De Lausanne | Affinity macroligands |
WO2001037803A2 (en) | 1999-11-15 | 2001-05-31 | Biocure, Inc. | Responsive polymeric hollow particles |
WO2001051092A2 (en) | 2000-01-07 | 2001-07-19 | University Of Washington | Enhanced transport of agents using membrane disruptive agents |
US6444254B1 (en) | 2000-03-03 | 2002-09-03 | Duke University | Microstamping activated polymer surfaces |
US7163712B2 (en) * | 2000-03-03 | 2007-01-16 | Duke University | Microstamping activated polymer surfaces |
AU2001246843A1 (en) * | 2000-04-05 | 2001-10-15 | Japan Chemical Innovation Institute | Novel material for use in separation and separating method using the same |
US6660247B1 (en) * | 2000-06-23 | 2003-12-09 | Battelle Memorial Institute | Multiple stimulus reversible hydrogels |
AU2001270231A1 (en) * | 2000-06-28 | 2002-01-08 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Localized delivery to a target surface |
EP1227321A1 (en) * | 2000-12-28 | 2002-07-31 | Institut für Bioanalytik GmbH | Reversible MHC multimer staining for functional purification of antigen-specific T cells |
JP4797143B2 (en) * | 2001-01-31 | 2011-10-19 | 独立行政法人産業技術総合研究所 | Catalytic reaction control method |
ES2545526T3 (en) | 2001-02-01 | 2015-09-11 | Sigma-Aldrich Co. Llc | Enhanced affinity matrices with enhanced visibility for molecular drag and immunoprecipitation applications |
US7718260B2 (en) * | 2001-07-31 | 2010-05-18 | Mitsubishi Rayon Co., Ltd. | Hollow fiber having inner wall into which comb polymer is introduced, hollow fiber impregnated with gel, and thin slice of fiber array |
US7456025B2 (en) * | 2001-08-28 | 2008-11-25 | Porex Corporation | Sintered polymer membrane for analyte detection device |
US20030108972A1 (en) * | 2001-12-06 | 2003-06-12 | Zweig Stephen Eliot | Tethered receptor-ligand reagent and assay |
US20040241173A1 (en) * | 2002-02-14 | 2004-12-02 | William Marsh Rice University | Fullerene (C60) vancomycin conjugates as improved antibiotics |
DE10224352A1 (en) * | 2002-06-01 | 2003-12-11 | Mueller Schulte Detlef | Thermosensitive polymer carrier with changeable physical structure for biochemical analysis, diagnostics and therapy |
WO2004009127A1 (en) * | 2002-07-19 | 2004-01-29 | Arizona Board Of Regents, Acting For And On Behalf Of, Arizona State University | Localized delivery system for phenstatin using n-isopropylacrylamide |
US7208089B2 (en) * | 2002-07-29 | 2007-04-24 | Mt Technologies, Inc. | Biomimetic membranes |
CN101301583A (en) * | 2002-07-29 | 2008-11-12 | Mt技术股份有限公司 | Biomimetic membranes |
US20040062882A1 (en) * | 2002-09-30 | 2004-04-01 | Andrea Liebmann-Vinson | Cell adhesion resisting surfaces |
CA2504929C (en) | 2002-11-05 | 2014-07-22 | Charles Allerson | Compositions comprising alternating 2'-modified nucleosides for use in gene modulation |
WO2004044141A2 (en) * | 2002-11-05 | 2004-05-27 | Isis Pharmaceuticals, Inc. | Conjugated oligomeric compounds and their use in gene modulation |
AU2002953073A0 (en) * | 2002-11-21 | 2003-01-16 | Access Pharmaceuticals Australia Pty Limited | Amplification of biotin-mediated targeting |
TWI354021B (en) * | 2002-12-23 | 2011-12-11 | Alcon Inc | Compositions and methods for inhibiting protein on |
US7083948B1 (en) | 2002-12-24 | 2006-08-01 | Immunex Corporation | Polypeptide purification reagents and methods for their use |
TWI257928B (en) * | 2002-12-27 | 2006-07-11 | Ind Tech Res Inst | Method for the separation of polysaccharides |
ATE531447T1 (en) | 2003-01-17 | 2011-11-15 | Cornell Res Foundation Inc | INJECTABLE HYDROGEL MICROSPHERES FROM AQUATE TWO-PHASE SYSTEM |
CA2513646C (en) * | 2003-01-24 | 2013-09-17 | Michael R. Emmert-Buck | Target activated microtransfer |
US7695752B2 (en) * | 2003-01-24 | 2010-04-13 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target activated microtransfer |
CA2515213A1 (en) * | 2003-02-11 | 2004-08-26 | University Of Washington | Stimuli-responsive polymer conjugates and related methods |
SE0300791D0 (en) * | 2003-03-20 | 2003-03-20 | Amersham Biosciences Ab | Use of ph-responsive polymers |
US7786213B2 (en) * | 2003-10-15 | 2010-08-31 | The Regents Of The University Of California | Biomacromolecule polymer conjugates |
DE10350248A1 (en) * | 2003-10-28 | 2005-06-16 | Magnamedics Gmbh | Thermosensitive, biocompatible polymer carriers with variable physical structure for therapy, diagnostics and analytics |
US20050096446A1 (en) * | 2003-10-29 | 2005-05-05 | Council Of Scientific And Industrial | Tri-block copolymers and a process for the preparation of the same |
EP2047866B1 (en) | 2003-11-05 | 2011-04-20 | PhotoBioMed Corporation | Bonding tissues and cross-linking proteins with naphthalimide compounds |
US7390628B2 (en) * | 2003-12-23 | 2008-06-24 | University Of Florida Research Foundation, Inc. | Microparticle-based diagnostic methods |
US8569474B2 (en) | 2004-03-09 | 2013-10-29 | Isis Pharmaceuticals, Inc. | Double stranded constructs comprising one or more short strands hybridized to a longer strand |
US8394947B2 (en) | 2004-06-03 | 2013-03-12 | Isis Pharmaceuticals, Inc. | Positionally modified siRNA constructs |
GB0412631D0 (en) * | 2004-06-07 | 2004-07-07 | Cambridge Applied Polymers Ltd | Polymer release system |
US7884086B2 (en) | 2004-09-08 | 2011-02-08 | Isis Pharmaceuticals, Inc. | Conjugates for use in hepatocyte free uptake assays |
CN101080168A (en) * | 2004-10-18 | 2007-11-28 | 纳幕尔杜邦公司 | Process for making antimicrobial polymer articles |
JP2006158305A (en) * | 2004-12-08 | 2006-06-22 | National Institute Of Advanced Industrial & Technology | Adsorbent for separating cell, adsorbent module for separating cell and method for separating cell |
US20080268013A1 (en) * | 2005-02-10 | 2008-10-30 | Emory University | Polyethylene Oxide Polymers Including Anti-Inflammatory Glycodendrons |
US8157807B2 (en) | 2005-06-02 | 2012-04-17 | The Invention Science Fund I, Llc | Skin treatment including patterned light |
JP2006312117A (en) * | 2005-05-06 | 2006-11-16 | Canon Inc | Separation material for physiologically active substance and its production method |
GB0515625D0 (en) * | 2005-07-29 | 2005-09-07 | Univ Manchester | Hydrogel particle |
JP2007071832A (en) * | 2005-09-09 | 2007-03-22 | Shiseido Co Ltd | Modified gold particles |
US7957466B2 (en) * | 2005-09-16 | 2011-06-07 | Sony Corporation | Adaptive area of influence filter for moving object boundaries |
US8114843B2 (en) * | 2005-11-18 | 2012-02-14 | The Regents Of The University Of California | Photoreactive regulator of protein function and methods of use thereof |
ES2779992T3 (en) | 2005-12-20 | 2020-08-21 | Univ Duke | Methods and compositions for delivering active agents with enhanced pharmacological properties |
US20130172274A1 (en) | 2005-12-20 | 2013-07-04 | Duke University | Methods and compositions for delivering active agents with enhanced pharmacological properties |
US8841255B2 (en) | 2005-12-20 | 2014-09-23 | Duke University | Therapeutic agents comprising fusions of vasoactive intestinal peptide and elastic peptides |
US7709227B2 (en) * | 2006-01-04 | 2010-05-04 | Phasebio Pharmaceuticals, Inc. | Multimeric ELP fusion constructs |
US7718193B2 (en) * | 2006-03-16 | 2010-05-18 | University Of Washington | Temperature- and pH-responsive polymer compositions |
FR2902799B1 (en) | 2006-06-27 | 2012-10-26 | Millipore Corp | METHOD AND UNIT FOR PREPARING A SAMPLE FOR THE MICROBIOLOGICAL ANALYSIS OF A LIQUID |
CN101479604B (en) * | 2006-06-30 | 2016-06-01 | Jnc株式会社 | The detection detection of object, reagents for quantitatively box and detection, quantitative approach |
US8569464B2 (en) | 2006-12-21 | 2013-10-29 | Emd Millipore Corporation | Purification of proteins |
US8362217B2 (en) | 2006-12-21 | 2013-01-29 | Emd Millipore Corporation | Purification of proteins |
WO2008079280A1 (en) | 2006-12-21 | 2008-07-03 | Millipore Corporation | Purification of proteins |
US7981688B2 (en) | 2007-03-08 | 2011-07-19 | University Of Washington | Stimuli-responsive magnetic nanoparticles and related methods |
US20100151465A1 (en) | 2008-03-27 | 2010-06-17 | Jingyue Ju | Selective Capture and Release of Analytes |
LT2220107T (en) | 2007-11-12 | 2017-04-10 | Chreto Aps | Dual affinity polypeptides for purification |
JP5184554B2 (en) * | 2007-12-28 | 2013-04-17 | オーソ・クリニカル・ダイアグノスティックス株式会社 | Detection method and quantification method of detection target |
WO2009084596A1 (en) * | 2007-12-28 | 2009-07-09 | Ortho-Clinical Diagnostics Kabushiki Kaisha | Detection method and determination method for detection target |
US8999702B2 (en) * | 2008-06-11 | 2015-04-07 | Emd Millipore Corporation | Stirred tank bioreactor |
EP2926825A1 (en) | 2008-06-27 | 2015-10-07 | Duke University | Therapeutic agents comprising elastin-like peptides |
KR101419259B1 (en) * | 2008-10-07 | 2014-07-17 | 어플라이드 바이오미메틱 에이/에스 | Biomimetic membrane formed from a vesicle-thread conjugate |
US20100150952A1 (en) * | 2008-11-07 | 2010-06-17 | University Of Washington | pH-RESPONSIVE POLYMER CARRIER COMPOSITIONS FOR CYTOSOLIC PROTEIN DELIVERY |
SG171446A1 (en) * | 2008-12-16 | 2011-07-28 | Millipore Corp | Stirred tank reactor and method |
US9041541B2 (en) | 2010-01-28 | 2015-05-26 | Seventh Sense Biosystems, Inc. | Monitoring or feedback systems and methods |
US20100256524A1 (en) | 2009-03-02 | 2010-10-07 | Seventh Sense Biosystems, Inc. | Techniques and devices associated with blood sampling |
WO2010101625A2 (en) | 2009-03-02 | 2010-09-10 | Seventh Sense Biosystems, Inc. | Oxygen sensor |
US9033898B2 (en) | 2010-06-23 | 2015-05-19 | Seventh Sense Biosystems, Inc. | Sampling devices and methods involving relatively little pain |
US9090663B2 (en) * | 2009-04-21 | 2015-07-28 | The Trustees Of Columbia University In The City Of New York | Systems and methods for the capture and separation of microparticles |
CN102483409B (en) * | 2009-05-29 | 2016-05-18 | Jnc株式会社 | Detect method for detecting and the quantitative approach of object |
US8426214B2 (en) * | 2009-06-12 | 2013-04-23 | University Of Washington | System and method for magnetically concentrating and detecting biomarkers |
EP2464370B1 (en) | 2009-08-14 | 2017-03-29 | Phasebio Pharmaceuticals, Inc. | Modified vasoactive intestinal peptides |
WO2011057131A1 (en) | 2009-11-09 | 2011-05-12 | Spotlight Technology Partners Llc | Polysaccharide based hydrogels |
US20110117668A1 (en) * | 2009-11-09 | 2011-05-19 | University Of Washington Through Its Center For Commercialization | Self-powered smart diagnostic devices |
US9080933B2 (en) | 2009-11-09 | 2015-07-14 | University Of Washington Through Its Center For Commercialization | Stimuli-responsive polymer diagnostic assay comprising magnetic nanoparticles and capture conjugates |
AU2010314994B2 (en) | 2009-11-09 | 2016-10-06 | Spotlight Technology Partners Llc | Fragmented hydrogels |
SG10201804385YA (en) | 2010-05-17 | 2018-06-28 | Emd Millipore Corp | Stimulus responsive polymers for the purification of biomolecules |
ES2561824T3 (en) | 2010-07-16 | 2016-03-01 | Seventh Sense Biosystems, Inc. | Low pressure environment for fluid transfer devices |
US20130158482A1 (en) | 2010-07-26 | 2013-06-20 | Seventh Sense Biosystems, Inc. | Rapid delivery and/or receiving of fluids |
WO2012021801A2 (en) | 2010-08-13 | 2012-02-16 | Seventh Sense Biosystems, Inc. | Systems and techniques for monitoring subjects |
WO2012064802A1 (en) | 2010-11-09 | 2012-05-18 | Seventh Sense Biosystems, Inc. | Systems and interfaces for blood sampling |
US8298298B1 (en) | 2010-12-22 | 2012-10-30 | Empire Development Technology LLC | Dyes with changeable solubilities, and methods for their use |
WO2012087310A1 (en) | 2010-12-22 | 2012-06-28 | Empire Technology Development Llc | Dyes with changeable solubilities, and methods for their use |
EP2701598A1 (en) | 2011-04-29 | 2014-03-05 | Seventh Sense Biosystems, Inc. | Systems and methods for collecting fluid from a subject |
US20130158468A1 (en) | 2011-12-19 | 2013-06-20 | Seventh Sense Biosystems, Inc. | Delivering and/or receiving material with respect to a subject surface |
KR102237667B1 (en) | 2011-04-29 | 2021-04-12 | 세븐쓰 센스 바이오시스템즈, 인크. | Delivering and/or receiving fluids |
EP2702406B1 (en) | 2011-04-29 | 2017-06-21 | Seventh Sense Biosystems, Inc. | Plasma or serum production and removal of fluids under reduced pressure |
ES2669190T3 (en) | 2011-06-06 | 2018-05-24 | Phasebio Pharmaceuticals, Inc. | Use of modified vasoactive intestinal peptides in the treatment of hypertension |
WO2013019714A1 (en) | 2011-07-29 | 2013-02-07 | The Trustees Of Columbia University In The City Of New York | Mems affinity sensor for continuous monitoring of analytes |
TWI425096B (en) * | 2012-02-10 | 2014-02-01 | Nat Applied Res Laboratories | Modifying surface of a substrate with bio-molecules |
US20150166654A1 (en) | 2012-05-30 | 2015-06-18 | Chugai Seiyaku Kabushiki Kaisha | Target tissue-specific antigen-binding molecule |
WO2014121802A1 (en) * | 2013-02-07 | 2014-08-14 | Zaghloul Mohammad Hosam Eldeen | Innovative nano-elisa single test for the detection of hcv, hiv antibodies and hbsag |
US9539338B2 (en) | 2013-04-22 | 2017-01-10 | Carnegie Mellon University | Polymer-based protein engineering methods to rationally tune enzyme activity, pH-dependence and stability |
US10359419B2 (en) * | 2013-10-02 | 2019-07-23 | General Electric Company | Methods for detection of target using affinity binding |
US20150093839A1 (en) * | 2013-10-02 | 2015-04-02 | General Electric Company | Methods and systems for detection of target and applications thereof |
DK3078744T3 (en) * | 2013-12-04 | 2020-09-28 | Chugai Pharmaceutical Co Ltd | ANTIGEN BINDING MOLECULES, THE ANTIGEN BINDING ACTIVITY OF WHICH VARIES ACCORDING TO THE CONCENTRATION OF COMPOUNDS, AND LIBRARIES OF THE MOLECULES |
US11052132B2 (en) | 2014-05-08 | 2021-07-06 | Phasebio Pharmaceuticals, Inc. | Methods and compositions for treating cystic fibrosis |
WO2016022696A1 (en) | 2014-08-05 | 2016-02-11 | The Trustees Of Columbia University In The City Of New York | Method of isolating aptamers for minimal residual disease detection |
CN114652817A (en) | 2015-02-09 | 2022-06-24 | 费斯生物制药公司 | Methods and compositions for treating muscle diseases and disorders |
JP6778380B2 (en) * | 2016-08-23 | 2020-11-04 | 昭和電工マテリアルズ株式会社 | Adsorbent |
GB201615989D0 (en) * | 2016-09-20 | 2016-11-02 | Imp Innovations Ltd | Drug Delivery |
DE102016119102A1 (en) | 2016-10-07 | 2018-04-12 | Forschungszentrum Jülich GmbH | Translocation of synthetic polymers through lipid membranes |
CN111201038A (en) | 2017-01-11 | 2020-05-26 | 戊瑞治疗有限公司 | PSGL-1 antagonists and uses thereof |
KR20190128198A (en) | 2017-03-14 | 2019-11-15 | 파이브 프라임 테라퓨틱스, 인크. | Antibodies that bind VISTA at acidic pH |
WO2018185503A1 (en) | 2017-04-07 | 2018-10-11 | The University Of Birmingham | Stimuli-responsive surfaces |
US10450345B2 (en) * | 2017-06-09 | 2019-10-22 | General Electric Company | Method of isolation of polypeptide-aptamer-polymer conjugates |
US11472894B2 (en) | 2018-07-23 | 2022-10-18 | Carnegie Mellon University | Enzyme-assisted ATRP procedures |
JP2020020719A (en) * | 2018-08-02 | 2020-02-06 | キヤノンメディカルシステムズ株式会社 | Analytic method, reagent kit, and analyzer |
KR20220084141A (en) * | 2019-10-21 | 2022-06-21 | 엠아이피 다이어그노스틱스 리미티드 | thermally reactive conjugate |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1986001902A1 (en) * | 1984-09-14 | 1986-03-27 | Unilever Plc | Specific binding materials, their preparation and use |
EP0470681A2 (en) * | 1990-08-08 | 1992-02-12 | W.R. Grace & Co.-Conn. | Cell clusters or sheets comprising a plurality of cell species and preparations thereof |
US5226902A (en) * | 1991-07-30 | 1993-07-13 | University Of Utah | Pulsatile drug delivery device using stimuli sensitive hydrogel |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4609707A (en) * | 1983-11-10 | 1986-09-02 | Genetic Systems Corporation | Synthesis of polymers containing integral antibodies |
US4752638A (en) * | 1983-11-10 | 1988-06-21 | Genetic Systems Corporation | Synthesis and use of polymers containing integral binding-pair members |
US4843010A (en) * | 1983-11-10 | 1989-06-27 | Genetic Systems Corporation | Polymerization-induced separation immunoassays |
WO1986002077A1 (en) * | 1984-10-02 | 1986-04-10 | Meade Harry M | Production of streptavidin-like polypeptides |
US4780409A (en) * | 1985-05-02 | 1988-10-25 | Genetic Systems Corporation | Thermally induced phase separation immunoassay |
JPS61265090A (en) * | 1985-05-17 | 1986-11-22 | Tanabe Seiyaku Co Ltd | Reversely soluble immobilized enzyme |
US4839293A (en) * | 1986-02-24 | 1989-06-13 | The Trustees Of Columbia University In The City Of New York | DNA encoding streptavidin, streptavidin produced therefrom, fused polypeptides which include amino acid sequences present in streptavidin and uses thereof |
US4946778A (en) * | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
US4971905A (en) * | 1987-08-11 | 1990-11-20 | Pacific Northwest Research Foundation | Diagnosis of cancerous or precancerous conditions in human secretory epithelia by enzyme activity of β-1-3N-acetylglucosaminyltransferase |
US5135876A (en) * | 1987-09-24 | 1992-08-04 | University Of Utah | Method and apparatus for the regulation of complex binding |
US5013669A (en) * | 1988-06-01 | 1991-05-07 | Smithkline Diagnostics, Inc. | Mass producible biologically active solid phase devices |
US5112770A (en) * | 1988-06-08 | 1992-05-12 | North Carolina State University | Precipitation of multivalent antiligands with affinity surfactants |
JPH0383914A (en) * | 1989-08-18 | 1991-04-09 | W R Grace & Co | Drug carrier |
DE69104573T2 (en) * | 1990-08-03 | 1995-04-20 | Philips Nv | Optical amplifier. |
US5417983A (en) * | 1992-02-19 | 1995-05-23 | Sagami Chemical Research Center | Drug release controlling material responsive to changes in temperature |
US5753261A (en) * | 1993-02-12 | 1998-05-19 | Access Pharmaceuticals, Inc. | Lipid-coated condensed-phase microparticle composition |
-
1996
- 1996-08-30 DE DE69620898T patent/DE69620898T2/en not_active Expired - Fee Related
- 1996-08-30 US US08/697,904 patent/US5998588A/en not_active Expired - Lifetime
- 1996-08-30 WO PCT/US1996/013874 patent/WO1997009068A2/en active IP Right Grant
- 1996-08-30 AU AU70110/96A patent/AU716154B2/en not_active Ceased
- 1996-08-30 CA CA002230557A patent/CA2230557A1/en not_active Abandoned
- 1996-08-30 EP EP96931427A patent/EP0851768B1/en not_active Expired - Lifetime
- 1996-08-30 JP JP9511275A patent/JP2000500733A/en not_active Ceased
- 1996-08-30 AT AT96931427T patent/ATE216594T1/en not_active IP Right Cessation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1986001902A1 (en) * | 1984-09-14 | 1986-03-27 | Unilever Plc | Specific binding materials, their preparation and use |
EP0470681A2 (en) * | 1990-08-08 | 1992-02-12 | W.R. Grace & Co.-Conn. | Cell clusters or sheets comprising a plurality of cell species and preparations thereof |
US5226902A (en) * | 1991-07-30 | 1993-07-13 | University Of Utah | Pulsatile drug delivery device using stimuli sensitive hydrogel |
Non-Patent Citations (7)
Title |
---|
CHILKOTI A ET AL: "Site-specific conjugation of a temperature-sensitive polymer to a genetically-engineered protein.", BIOCONJUG CHEM, NOV-DEC 1994, VOL. 5, NO. 6, PAGE(S) 504-7, XP002034311 * |
G. CHEN ET AL.: "Preparation and properties of thermoreversible, phase-separating enzyme-oligo(N-isopropylacrylamide) conjugates", BIOCONJUGATE CHEMISTRY, vol. 4, no. 6, November 1993 (1993-11-01) - December 1993 (1993-12-01), WASHINGTON US, pages 509 - 514, XP002034312 * |
JING PING CHEN ET AL: "POLYMER-PROTEIN CONJUGATES I. EFFECT OF PROTEIN CONJUGATION ON THE CLOUD POINT OF POLY (N-ISOPROPYLACRYLAMIDE)", BIOMATERIALS, vol. 11, no. 9, 1 November 1990 (1990-11-01), pages 625 - 630, XP000172542 * |
JING PING CHEN ET AL: "POLYMER-PROTEIN CONJUGATES II. AFFINITY PRECIPITATION SEPARATION OF HUMAN IMMUNOGAMMAGLOBULIN BY A POLY(N-ISOPROPYLACRYLAMIDE)-PROTEIN A CONJUGATE", BIOMATERIALS, vol. 11, no. 9, 1 November 1990 (1990-11-01), pages 631 - 634, XP000172543 * |
N. MONJI ET AL.: "Application of a thermally-reversible polymer-antibody conjugate in a novel membrane-based immunoassay", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 172, no. 2, 30 October 1990 (1990-10-30), ORLANDO, FL US, pages 652 - 660, XP002034313 * |
STAYTON PS ET AL: "Control of protein-ligand recognition using a stimuli-responsive polymer.", NATURE, NOV 30 1995, VOL. 378, NO. 6556, PAGE(S) 472-4, XP002034314 * |
TAKEI Y G ET AL: "TEMPERATURE-RESPONSIVE BIOCONJUGATES. 1. SYNTHESIS OF TEMPERATURE-RESPONSIVE OLIGOMERS WITH REACTIVE END GROUPS AND THEIR COUPLING TO BIOMOLECULES", BIOCONJUGATE CHEMISTRY, vol. 4, no. 1, 1 January 1993 (1993-01-01), pages 42 - 46, XP000336591 * |
Also Published As
Publication number | Publication date |
---|---|
ATE216594T1 (en) | 2002-05-15 |
DE69620898T2 (en) | 2002-11-07 |
AU7011096A (en) | 1997-03-27 |
CA2230557A1 (en) | 1997-03-13 |
EP0851768A2 (en) | 1998-07-08 |
JP2000500733A (en) | 2000-01-25 |
DE69620898D1 (en) | 2002-05-29 |
US5998588A (en) | 1999-12-07 |
EP0851768B1 (en) | 2002-04-24 |
AU716154B2 (en) | 2000-02-17 |
WO1997009068A2 (en) | 1997-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1997009068A3 (en) | Interactive molecular conjugates | |
ATE384792T1 (en) | ANTIBODY VARIANTS WITH HIGHER BINDING AFFINITIES COMPARED TO PARENTAL ANTIBODIES | |
CA2117477A1 (en) | Multivalent single chain antibodies | |
WO1999023221A3 (en) | Multivalent antigen-binding proteins | |
WO2001079479A3 (en) | Methods for selective targeting | |
ATE461211T1 (en) | LIGANDS WITH ANTIBODY BINDING AFFINITY | |
DE69332858D1 (en) | RESTRICTED MULTIFUNCTIONAL REAGENTS FOR SURFACE MODIFICATION | |
DE69409788T2 (en) | METHODS FOR ANALYSIS / SEPARATION | |
ATE474854T1 (en) | RSV NEUTRALIZING ANTIBODIES WITH VERY HIGH AFFINITY | |
WO1999006834A3 (en) | Methods for identifying ligand specific binding molecules | |
FI102921B1 (en) | Process for the preparation of biologically active reagents from succinimide-containing polymers, analytical element and methods for their use | |
DE69114394T2 (en) | Analytical element with biologically active reagent and method of using the reagent. | |
DE69430523T2 (en) | PRODUCTION OF PHOTOPROTEIN CONJUGATES AND METHOD FOR THEIR USE | |
NZ235480A (en) | Monomeric avidin bound to a solid substrate; use in chromatography | |
DE69619257D1 (en) | THE CONJUGATION OF LIGANDS TO IMMOBILIZED PROTEINS IN AN ORGANIC SOLVENT | |
IE880701L (en) | Immunoglobulin conjugates | |
WO2001050127A3 (en) | Screening using biological target molecules with metal-ion binding sites | |
Cho et al. | Site-directed immobilization of antibody onto solid surfaces for the construction of immunochip | |
WO1997020048A3 (en) | Modified SFV molecules which mediate adhesion between cells and uses thereof | |
WO2005000896A3 (en) | Polypeptides that bind an anti-tissue factor antibody and uses thereof | |
EP1950300A3 (en) | Antibody variants with higher binding affinity compared to parent antibodies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AU BB BG BR CA CN CU CZ EE GE HU IL IS JP KP KR LK LR LT LV MG MK MN MX NO NZ PL RO SG SI SK TR TT UA UZ VN AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AU BB BG BR CA CN CU CZ EE GE HU IL IS JP KP KR LK LR LT LV MG MK MN MX NO NZ PL RO SG SI SK TR TT UA UZ VN AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
ENP | Entry into the national phase |
Ref document number: 2230557 Country of ref document: CA Ref country code: CA Ref document number: 2230557 Kind code of ref document: A Format of ref document f/p: F |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 1997 511275 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1996931427 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1996931427 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1996931427 Country of ref document: EP |